View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Nivolumab 3 / Ipilimumab 1, Colorectal Carcinoma, first-line
Protocol-ID: 2011 V1.0 (Mini), NIVO3/IPIL1, colorect. Ca, first lineIndication(s)
- Colon Cancer (Mismatch Repair - deficient / Microsatellite Instability - high (dMMR/MSI-H), POLE/POLD1 mutation); ICD-10 C18.0, C18.2, C18.3, C18.4, C18.5, C18.6, C18.7, C18.8, C19
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 27.03.2022